Follow Newser on Twitter   Friend Newser on Facebook
Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Feds OK Wyeth's New Antidepressant

Faced with generic threats to its popular Effexor XR, company banking on Pristiq

By Harry Kimball,  Newser Staff

Posted Feb 29, 2008 7:41 PM CST

(Newser) – Antidepressant Effexor XR will soon lose patent protection, and maker Wyeth is hoping Pristiq, the successor drug approved today by the FDA, will soften the financial blow. Higher-ups at the company gush over Pristiq's advantages, including zero acclimation time and no liver interaction, and hope...   Read full story »

COMMENTS
You need to Log in to Newser to comment. Don't have an account yet? Sign up now!
There are no comments
A snapshot of the day's best news stories.
 

More Newser Stories

Antidepressant Studies Distort Drugs' Usefulness


NEWS FROM OUR PARTNERS
Other Sites We Like:   24/7 Wall St.   |   BuzzFeed   |   Cracked   |   Timelines   |   Geek Sugar   |   Business Insider   |   HuffPost Entertainment